UNIGE document Scientific Article - Case report
previous document  unige:97068  next document
add to browser collection
Title

First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies

Authors show hidden authors show all authors [1 - 9]
Published in OncoImmunology. 2017, vol. 6, no. 8, p. e1338235
Abstract Chordoma is a rare tumor of notochordal origin, currently principally treated by surgery and/or irradiation. Here, we describe the clinical outcome of 3 consecutive patients with metastatic and locally advanced chordoma, treated with different immunotherapeutic approaches. All patients presented fast growing tumors and failure of standard therapies. One was treated with a tumor-based vaccine, the 2 others with anti-PD1 antibodies, all with impressive clinical and radiological responses. We therefore propose that chordoma is an immunogenic tumor and thus that translational and clinical research is necessary to develop rationally designed immunotherapy approaches.
Identifiers
PMID: 28919999
Full text
Article (Published version) (957 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research groups Immunothérapie des cancers (42)
Groupe Mach Nicolas (oncologie) (654)
Groupe Becker Minerva (imagerie ORL) (683)
Groupe Mach Nicolas (oncologie) (654)
Citation
(ISO format)
MIGLIORINI, Denis et al. First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies. In: OncoImmunology, 2017, vol. 6, n° 8, p. e1338235. https://archive-ouverte.unige.ch/unige:97068

167 hits

6 downloads

Update

Deposited on : 2017-09-27

Export document
Format :
Citation style :